Search IPOs
Grey Market Premium · Jan 21 – Jan 23, 2026 · Issue Price ₹135
KRM Ayurveda IPO GMP: ₹22.50 — 16.7% expected gain as of Jan 29, 2026
The KRM Ayurveda IPO Grey Market Premium (GMP) is currently trading at ₹22.50 in the unofficial grey market. Based on this, the expected listing price is ₹157.50, implying a +16.7% gain over the issue price of ₹135. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Grey market premium over time (₹)
Latest 16 data points, most recent first
| Date / Time | GMP (₹) | Exp. Listing | Exp. Gain |
|---|---|---|---|
| Jan 29, 2026 5:17 pm | +₹22.50 | ₹157.50 | +16.7% |
| Jan 28, 2026 4:39 pm | +₹22.50 | ₹157.50 | +16.7% |
| Jan 27, 2026 4:37 pm | +₹20.00 | ₹155.00 | +14.8% |
| Jan 26, 2026 4:17 pm | +₹19.00 | ₹154.00 | +14.1% |
| Jan 25, 2026 2:54 pm | +₹17.00 | ₹152.00 | +12.6% |
| Jan 24, 2026 6:32 pm | +₹17.00 | ₹152.00 | +12.6% |
| Jan 23, 2026 2:15 pm | +₹17.00 | ₹152.00 | +12.6% |
| Jan 22, 2026 7:41 pm | +₹16.00 | ₹151.00 | +11.9% |
| Jan 21, 2026 1:18 pm | +₹12.00 | ₹147.00 | +8.9% |
| Jan 20, 2026 12:39 pm | +₹21.00 | ₹156.00 | +15.6% |
| Jan 19, 2026 4:35 pm | +₹20.00 | ₹155.00 | +14.8% |
| Jan 18, 2026 1:00 pm | +₹20.00 | ₹155.00 | +14.8% |
| Jan 17, 2026 6:59 pm | +₹20.00 | ₹155.00 | +14.8% |
| Jan 16, 2026 2:07 pm | +₹18.00 | ₹153.00 | +13.3% |
| Jan 15, 2026 11:07 pm | +₹15.00 | ₹150.00 | +11.1% |
| Jan 14, 2026 4:14 pm | +₹0.00 | ₹135.00 | +0.0% |
The KRM Ayurveda IPO GMP (Grey Market Premium) is the unofficial pre-listing price at which shares trade in informal markets before the IPO is listed on the stock exchange. Currently, the KRM Ayurveda IPO GMP stands at ₹22.50, implying an expected listing price of ₹157.50.
GMP = Expected Listing Price − Issue Price. If the issue price of KRM Ayurveda IPO is ₹135 and the expected listing is ₹157.50, then GMP = ₹22.50. The expected gain percentage is calculated as (GMP ÷ Issue Price) × 100. For KRM Ayurveda IPO, that is 16.7%.
GMP is not regulated by SEBI and reflects informal market activity. It can fluctuate significantly day-to-day and should not be the sole basis for investment decisions. Many IPOs with high GMP have listed below expectations, and vice versa. Always refer to subscription data, financials, and the DRHP before investing.
We classify GMP signals as: Hot (expected gain ≥30%), Warm (10–30%), Neutral (0–10%), and Weak (negative GMP). KRM Ayurveda IPO is currently classified as Warm.
The current Grey Market Premium for KRM Ayurveda IPO is ₹22.50 as of Jan 29, 2026. Expected listing price: ₹157.50, expected gain: 16.7%. GMP data is updated periodically from grey market sources.
A GMP of ₹22.50 means that in the unofficial grey market, KRM Ayurveda IPO shares are trading at ₹22.50 above the issue price. With an issue price of ₹135, this implies an expected listing at ₹157.50 (16.7% gain). GMP is purely indicative and actual listing price depends on market conditions.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Kostak rate data for KRM Ayurveda IPO will be available once reported from grey market sources. Kostak represents the per-application premium in informal markets.
KRM Ayurveda IPO is expected to list on January 29, 2026 on NSE SME platform. The GMP on listing day is a strong short-term indicator of opening price.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.